Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium undecylenate is the calcium salt of undecylenic acid, an 11-carbon mono-unsaturated fatty acid with broad-spectrum antifungal activity. It acts primarily by inhibiting the morphogenesis of *Candida albicans*, preventing its transition from yeast to invasive hyphal form, which is critical for fungal virulence and infection. Calcium undecylenate and other undecylenates are used topically as antifungal agents in the treatment of skin infections such as athlete’s foot (tinea pedis), jock itch (tinea cruris), and other dermatophytic infections. The mechanism involves interference with fungal cell morphogenesis and possibly disruption of cellular pH homeostasis[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium undecylenate.